Nuvalent

NUVL40

$108.64arrow_drop_up24.23%$21.19

NUVL40

$108.64

arrow_drop_up24.23%$21.19

Performance History

Key Stats
Open	$102.70
Prev. Close	$87.45
EPS	-2.79
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	93.02	113.51
52 Week Range	39.86	113.51

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.79

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Nuvalent (NUVL)

Nuvalent, Inc. (NUVL) is a biotechnology company focused on discovering and developing precision medicines for patients with cancer. The company's mission is to provide targeted therapies that can overcome the limitations of current treatments and improve patient outcomes. With a deep understanding of the underlying biology of cancer, Nuvalent is leveraging its expertise in structure-based drug design and precision medicine to develop novel therapies that target specific molecular alterations driving cancer growth.

One of Nuvalent's key areas of focus is the development of targeted therapies for patients with oncogenic driver mutations. These mutations are specific genetic alterations that drive the growth and survival of cancer cells. By targeting these driver mutations with precise and potent therapies, Nuvalent aims to deliver more effective and less toxic treatments for patients with cancer.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. James R. Porter Ph.D.
Headquarters: Cambridge
Employees: 78
Exchange: NASDAQ

Keep an eye on Nuvalent

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Nuvalent's (NUVL) price per share?

The current price per share for Nuvalent (NUVL) is $110.37. The stock has seen a price change of $21.19 recently, indicating a 24.23% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Nuvalent (NUVL)?

For Nuvalent (NUVL), the 52-week high is $113.51, which is 4.48% from the current price. The 52-week low is $39.86, the current price is 172.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Nuvalent (NUVL) a growth stock?

Nuvalent (NUVL) has shown an average price growth of 0.41% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nuvalent as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Nuvalent (NUVL) stock price performance year to date (YTD)?

As of the latest data, Nuvalent (NUVL) has a year-to-date price change of 42.76%. Over the past month, the stock has experienced a price change of 51.08%. Over the last three months, the change has been 40.76%. Over the past six months, the figure is 34.46%.

help

Is Nuvalent (NUVL) a profitable company?

Nuvalent (NUVL) has a net income of -$126.22M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$149.49M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Nuvalent (NUVL)?

Nuvalent (NUVL) has a market capitalization of $5.67B. The average daily trading volume is 603.9K, indicating the stock's liquidity and investor engagement.